» Articles » PMID: 10024373

The Mineralization Density of Iliac Crest Bone from Children with Osteogenesis Imperfecta

Overview
Specialty Pathology
Date 1999 Feb 19
PMID 10024373
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

We studied iliac crest biopsy cores taken from young individuals with osteogenesis imperfecta of several types, and from age-matched normals; the same samples had been used in prior studies using conventional light microscopic histomorphometric procedures. The PMMA blocks were micro-milled to a fine finish, carbon coated, and imaged using backscattered electrons (BSE) in an automated digital scanning electron microscope (SEM). For comparison of BSE signal levels between samples, microscope operation parameters were standardized by reference to halogenated dimethacrylate standards, and recording data from stereological arrays of 512*512 nonoverlapping pixels at 3.5 micrometer separation. All OI types showed higher average mineralization densities than age- and site-matched normals. This is interpreted as the result of the failure in matrix assembly, such that it has a higher water volume fraction available for mineral deposition. Added to the net deficit in bone quantity, the predicted higher stiffness of the more mineralized bone will account for much of the observed 'brittleness' that characterizes this class of genetic disease. The mean mineralization density, which was higher in types III, IV, and V than in type I, appears to be correlated with disease severity.

Citing Articles

Improvement of bone properties in children with osteogenesis imperfecta after pamidronate: a bone biopsy study.

Farlay D, Cornier M, Rizzo S, Cormier-Daire V, Charpie M, Pinto G JBMR Plus. 2025; 9(2):ziae161.

PMID: 39822213 PMC: 11736749. DOI: 10.1093/jbmrpl/ziae161.


Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.

Misof B, Fratzl-Zelman N Calcif Tissue Int. 2024; 115(6):777-804.

PMID: 39231826 DOI: 10.1007/s00223-024-01263-8.


A Dyadic Nosology for Osteogenesis Imperfecta and Bone Fragility Syndromes 2024.

Sillence D Calcif Tissue Int. 2024; 115(6):873-890.

PMID: 38942908 PMC: 11607092. DOI: 10.1007/s00223-024-01248-7.


A Retrospective Study of the Presentation, Diagnosis, Management, and Outcomes of 27 Patients with Osteogenesis Imperfecta at a Single Center in Türkiye.

Gokmen M, Mirioglu A, Kundakci B, Boga I, Bicer O Med Sci Monit. 2024; 30:e944364.

PMID: 38807347 PMC: 11469422. DOI: 10.12659/MSM.944364.


Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta.

Arundel P, Bishop N Calcif Tissue Int. 2024; 115(6):812-827.

PMID: 38553634 PMC: 11606989. DOI: 10.1007/s00223-024-01202-7.